金吾财讯 | STAAR Surgical（STAA）盘前股价上涨19%，主要因该公司发布的2026年第一季度净销售额指引超9000万美元，较上年同期增长逾一倍。这一增长主要得益于中国市场的强劲反弹，去年经销商去库存后，中国市场需求显著回升。此外，美洲市场持续实现两位数增长。
公司预计，得益于销售杠杆改善及成本管控，调整后息税折旧摊销前利润（EBITDA）将获得显著提升。不过管理层指出，中东、欧洲、中东和非洲（EMEA）以及亚太部分地区持续存在的地缘政治和宏观经济压力，可能成为公司持续增长的潜在阻力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.